To explore the involvement of RANKL in CSR’s anti-RA mechanisms, we will, in the future, investigate whether CSR inhibits RANKL production by suppressing JAK2/STAT3 pathway in IL-6/sIL-6R-stimulated RA-FLS. Here, TNFSF11 is linked to rheumatoid arthritis.